DURHAM, N.C. & SEATTLE-- November 13, 2023--Pioneering epigenome editing company Tune Therapeutics has announced it is working on a new and potentially curative approach to treating chronic HBV infection. The...
TargeGen closes on $40 million venture round
News | 07. 12. 2007
TargeGen
TargeGen, Inc. has announced that the Company has successfully closed a $40M venture round of financing.
